Fatty Liver Disease in Nordic Countries

Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorCopenhagen University Hospital, Hvidovre

About this trial

A prospective cohort study, which aims to systematically evaluate biomarkers and potential targets in NAFLD and NASH.

Eligibility criteria

Qualifiers

Non-alcoholic fatty liver disease and

Healthy volunteers

Disqualifiers

Other liver diseases than non-alcoholic fatty liver disease

Lack of informed consent

Trial design

Treatments tested in this trial

  • Proteomics
  • Transcriptomics
  • Genomics

Treatment groups

No treatment groups listed